J.N.B. Pharma Private Limited
Pharmaceutical trading and distribution of medical goods.
1999 | Mumbai, Maharashtra (India) | Active
J.N.B. Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.40 M
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -0.51%
- Profit Growth 88.09%
- Ebitda 79.05%
- Net Worth 13.74%
- Total Assets 62.01%
About J.N.B. Pharma
J.N.B. Pharma Private Limited (JPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 August 1999 and has a history of 25 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Sonal Ganatra and Bharat Ganatra serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1999PTC121173
- Company No.
121173
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at J.N.B. Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Ganatra  | Managing Director | 06-Aug-1999 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sonal Ganatra | Director | 28-Apr-2012 | Current |
Financial Performance of J.N.B. Pharma.
J.N.B. Pharma Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 0.51% decrease. The company also saw a substantial improvement in profitability, with a 88.09% increase in profit. The company's net worth Soared by an impressive increase of 13.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J.N.B. Pharma?
In 2019, J.N.B. Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at J.N.B. Pharma?
Unlock and access historical data on people associated with J.N.B. Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J.N.B. Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J.N.B. Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
